News | September 17, 2021
Skyhawk Therapeutics Completes New Investment Round
Read More
News | September 17, 2021
DICE Therapeutics Announces Pricing of Upsized Initial Public Offering
Read More
News | September 17, 2021
ImCheck Presents Preliminary Patient Response Data from the Phase I/IIa EVICTION Trial with ICT01 at ESMO Congress 2021
Read More
Press Release | August 18, 2021
Immunitas Therapeutics Completes $58 Million Series B Financing to Advance Pipeline into the Clinic and Expand Single Cell Analysis Drug Development Platform for Immuno-Oncology and Other Diseases
Read More
News | July 13, 2021
ImCheck Publishes Seminal Paper in Cell Reports Elucidating How Butyrophilins Activate Vγ9Vδ2 T cell Function Against Tumor Cells
Read More
News | June 1, 2021
Alloy Therapeutics and Pyxis Oncology Form Kyma Therapeutics to Develop Novel Immune-Modulating Antibodies for Cancer and Autoimmune Diseases
Read More
News | May 18, 2021
Interius BioTherapeutics Raises $76M Series A Financing to Advance Breakthrough Cell and Gene Therapy Platform
Read More
Press Release | March 31, 2021
Entrada Therapeutics Announces Closing of $116 Million Series B Financing
Read More
Press Release | March 30, 2021
Pyxis Oncology Closes $152 Million Series B Financing to Further Advance Portfolio of Biologics
Read More
Press Release | March 18, 2021
Pyxis Oncology Announces Worldwide Licensing Agreement with Pfizer to Develop and Commercialize Multiple Antibody-Drug Conjugates
Read More
News | March 18, 2021
CAR-M era begins as Carisma doses first patient
Read More
News | January 8, 2021
DiCE gets its ‘library’ card ready as it speeds development of DNA database-derived molecules with more investor cash
Read More
News | January 7, 2021
CARISMA Therapeutics Completes Series B Funding to Advance Development of Novel CAR-Macrophage Immunotherapies
Read More
Press Release | December 21, 2020
Orchard Therapeutics Receives EC Approval for Libmeldy™ for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD)
Read More
News | November 20, 2020
Lilly, Precision Biosciences team up on Duchenne gene therapy in $135M deal
Read More
Press Release | November 5, 2020
Orchard Therapeutics Announces New OTL-201 Clinical Data in Sanfilippo Syndrome Type A (MPS-IIIA) Accepted for Oral Presentation at 62nd American Society of Hematology Annual Meeting
Read More
News | November 3, 2020
Orbus Therapeutics Publishes in Oncotarget Scientific Journal
Read More
Press Release | October 22, 2020
Orbus Therapeutics Expands Series A Financing to $71 Million to Support Ongoing STELLAR Phase 3 Study in Rare Brain Cancer
Read More
Press Release | October 19, 2020
Aptinyx Reports Positive, Statistically Significant, Top-line Data From Phase 2 Study of NYX-783 in Patients With Post-Traumatic Stress Disorder
Read More
Press Release | October 15, 2020
Precision BioSciences Announces U.S. Patent Trial and Appeal Board Upholds Allogeneic CAR T Patents
Read More
